|
| 36592003 | Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors. | Pediatr Blood Cancer | 2023 |
| 37593416 | Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. | HGG Adv | 2023 |
| 37651264 | Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. | Clin Cancer Res | 2023 |
| 37568669 | Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors. | Cancers (Basel) | 2023 |
| 37058010 | Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). | Clin Cancer Res | 2023 |
| 37343199 | Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. | J Clin Oncol | 2023 |
| 35276672 | Authors' Reply to the Letter to the Editor by Daniel M. Green. | J Natl Compr Canc Netw | 2022 |
| 35650195 | The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. | Nat Commun | 2022 |
| 35342935 | White paper: Oncofertility in pediatric patients with Wilms tumor. | Int J Cancer | 2022 |
| 35697807 | Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. | Nat Biotechnol | 2022 |
| 35934010 | Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. | Lancet Oncol | 2022 |
| 35284040 | Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients. | Oncotarget | 2022 |
| 33408328 | Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. | Cancer Gene Ther | 2021 |
| 33614514 | Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2. | Front Oncol | 2021 |
| 33503424 | Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. | Cell Rep | 2021 |
| 34416705 | Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. | J Natl Compr Canc Netw | 2021 |
| 33994796 | A Phase I Trial of the MET/<i>ALK/ROS1</i> Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies. | Onco Targets Ther | 2021 |
| 32483731 | Aerosolized Chemotherapy for Osteosarcoma. | Adv Exp Med Biol | 2020 |
| 32081846 | Immuno-genomic landscape of osteosarcoma. | Nat Commun | 2020 |
| 33050651 | Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. | Cancers (Basel) | 2020 |
| 32630797 | IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. | Cancers (Basel) | 2020 |
| 32926409 | A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study. | Cancer | 2020 |
| 32134700 | Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. | J Clin Oncol | 2020 |
| 30287223 | Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. | Clin Genitourin Cancer | 2019 |
| 31325873 | Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. | Eur J Cancer | 2019 |
| 30733229 | Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. | Clin Cancer Res | 2019 |
| 28611244 | <sup>18</sup>F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. | J Nucl Med | 2018 |
| 30241221 | Health-Related Quality of Life and Survival Outcomes of Pediatric Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different Resources. | J Glob Oncol | 2018 |
| 30017298 | Tumor thrombus in the large veins draining primary pelvic osteosarcoma on cross sectional imaging. | Eur J Radiol | 2018 |
| 29871905 | Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. | Clin Cancer Res | 2018 |
| 30697457 | Multi-level otsu method to define metabolic tumor volume in positron emission tomography. | Am J Nucl Med Mol Imaging | 2018 |
| 29357275 | Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study. | Radiology | 2018 |
| 29592877 | Analysis of HSP27 and the Autophagy Marker LC3B<sup>+</sup> Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients. | Mol Cancer Ther | 2018 |
| 28988289 | Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. | Fam Cancer | 2018 |
| 29212731 | Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor. | Oncologist | 2018 |
| 27573717 | Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population. | Pediatr Blood Cancer | 2017 |
| 28965545 | PET/CT of Osteosarcoma and Ewing Sarcoma. | Semin Roentgenol | 2017 |
| 28928879 | <sup>18</sup>F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone. | J Cancer | 2017 |
| 28631382 | A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. | Int J Cancer | 2017 |
| 27696711 | Ewing sarcoma family of tumors in children younger than 10 years of age. | Pediatr Blood Cancer | 2017 |
| 27082077 | Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. | Pediatr Blood Cancer | 2016 |
| 26411434 | Cardiovascular involvement by osteosarcoma: an analysis of 20 patients. | Pediatr Radiol | 2016 |
| 26345283 | Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. | Br J Clin Pharmacol | 2016 |
| 27362300 | A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. | Pediatr Blood Cancer | 2016 |
| 27216741 | Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. | Ann Surg Oncol | 2016 |
| 27576731 | IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. | J Natl Cancer Inst | 2016 |
| 25381958 | Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma. | Pediatr Blood Cancer | 2015 |
| 26461056 | Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. | Br J Cancer | 2015 |
| 25772182 | Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. | Int J Radiat Oncol Biol Phys | 2015 |
| 25422914 | Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. | Br J Cancer | 2015 |